Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-12 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.55 | 2e-06 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |